Czechia, March 6 -- Czechia based Takeda Pharmaceuticals Czech Republic s.r.o. has secured contract from Nemocnice Pardubickeho kraje, a.s. for Pharmaceutical products - Medicinal preparation of ATC group L04AG05 with the active substance VEDOLIZUMAB. The value of the contract is worth 852497620 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....